Research. Advocacy. Support.
Know Your Risks
About 20 to 25 percent of women diagnosed with ovarian cancer have a hereditary tendency to develop the disease.
We’re excited to announce that OCRFA’s new and refreshed website is live. The new site is reflective of the merger of Ovarian Cancer Research Fund and the Ovarian Cancer National Alliance to become Ovarian Cancer Research Fund Alliance or OCRFA, the largest and oldest non-profit organization dedicated to advancing cancer research, while supporting women and… More
On September 7th, the FDA issued an important safety communication about tests marketed as ovarian cancer screening tests, including the ROCA Test developed by Abcodia Incorporated. The FDA states, “despite extensive research and published studies, there are currently no screening tests for ovarian cancer that are sensitive enough to reliably screen for ovarian cancer without a… More
Our #30DaysofTeal campaign spotlighted education and awareness facts about ovarian cancer. You, this amazing and strong community helped us educate 2.5 MILLION people about ovarian cancer throughout September. But awareness doesn’t stop today. Follow us year-round for the latest updates on research, advocacy and news about ovarian cancer. Today’s #30DaysofTeal sponsored by AstraZeneca US Community… More
A Taste of our 12TH Annual Gala! Masters of Ceremonies Tommy McFly, Kelly Collis & Jen Richer&nd...February 22, 2017 @ 6:00 pm - 9:00 pm EST
At the 2016 Ovarian Cancer National Conference, attendees heard from the country’s top researc...July 7, 2017 @ 8:00 am - July 9, 2017 @ 5:00 pm EDT
OCRFA’s Super Saturday is a daylong shopping event that brings top luxury name brands in high ...July 29, 2017 @ 8:00 am - 5:00 pm EDT